Navigating a rapidly shifting Immunology landscape
The Immunology space is evolving faster than ever. Innovation is accelerating across modalities—oral small molecules, long-acting mechanisms, remission-focused therapies, combinations and biomarker-guided segmentation. At the same time, competition is intensifying, with broader multi-indication pipelines, overlapping portfolios within companies and expanding biosimilar pressure.
For market access teams, these shifts raise critical questions. How will payers interpret new endpoints? How will pricing logic adapt to earlier-line positioning? And how can manufacturers preserve value in classes where differentiation is tightening?
A comprehensive look at how payers respond
To help address these questions, Elevio Group has launched a new study examining how access frameworks are evolving across Immunology. Through payer interviews and discussions with market access leaders in the US and EU, the research explores how payers perceive emerging trends and how these perceptions vary by market and therapeutic class.
The study also investigates how payers assess multi-indication assets and what pressures biosimilars create for both innovative and established treatments. The findings offer a clearer view of the levers that truly shape access as Immunology continues to evolve.
Guidance for Market Access leaders
This research equips Market Access leaders to better anticipate how their Immunology assets will be evaluated, priced and positioned. It highlights what payers value, what they discount and what evidence they expect as the next generation of therapies emerges. These insights support stronger clinical planning, sharper value propositions and more confident launch preparation. Some of the learnings will be shared at ISPOR Europe 2025 in Glasgow.
Elevio Group’s expertise in Immunology
With deep experience across Immunology, Elevio Group partners with manufacturers to navigate the access complexities of this dynamic therapeutic area. This study reinforces our commitment to delivering practical, evidence-based insights that help teams make smarter strategic decisions.
For more information, contact info@eleviogroup.com
